Cannabiz Australia headlines were instructive this morning.
They ran with the positive one at the top, but even that had a note of caution… in the story
Meanwhile of the 9 headline stories 5 weren’t really what those people who sit in offices wearing crisp white shirts would call, “market positive sentiment” or as we say in English, it all looks a bit crapola.
Biortica eyes facility as OneLife subsidiaries enter administration
Two subsidiaries of OneLife Botanicals have become the latest firms to hit the financial wall, with Biortica Agrimed among those showing an interest in acquiring the firm’s manufacturing facility.
Releaf Group saga rolls on as anger grows over Vitura-Crisci Group deal
Acrimony is rising among creditors, shareholders and franchisees over the sale of Releaf Group’s assets to Vitura Health and Crisci Group as the administrator admitted he was “in the dark” over the transactio
Aether Pacific facing liquidation with creditors owed NZ$9m
Christchurch-based Aether Pacific Pharmaceuticals, formerly known as Medical Kiwi, is facing liquidation with creditors owed nearly NZ$9 million.
LGP losses up despite positive operating cash flow and higher revenue
Little Green Pharma saw losses deepen in the first half of the financial year despite overseeing a positive EBITDA result and significantly higher revenue.
Althea granted ASX suspension amid failure to lodge notices
Althea has been voluntarily suspended from the Australian Securities Exchange after failing to release mandatory documents to the market.
Read all at (paywall)
